Page
%P
-
Book
-
Chapter
HER2-Positive Metastatic Breast Cancer: First-Line Treatment
Prognoses for patients with breast cancer overexpressing the human epidermal growth factor receptor 2 (HER2) have markedly improved with the administration of anti-HER2-targeted therapy.
-
Article
Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm
To summarize and discuss the available evidence and ongoing efforts in order to establish the efficacy and safety of immunotherapeutic approaches in HER2-positive breast cancer.